Cargando…

Feasibility of detecting myocardial ischemia using first-pass contrast MRI and regadenoson

Detalles Bibliográficos
Autores principales:	Lyons, Matthew, Javidan-Nejad, Cylen, Saeed, Ibrahim M, Lesniak, Donna, McNeal, Gary R, Priatna, Agus, Gropler, Robert J, Woodard, Pamela K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304913/ http://dx.doi.org/10.1186/1532-429X-14-S1-P11

Ejemplares similares

Feasibility of MRI attenuation correction in cardiac FDG-PET
por: Lau, Jeffrey M, et al.
Publicado: (2013)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

The EXERRT trial: “EXErcise to Regadenoson in Recovery Trial”: A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol
por: Thomas, Gregory S., et al.
Publicado: (2017)

Quantification of global myocardial oxygenation in humans: initial experience
por: McCommis, Kyle S, et al.
Publicado: (2010)

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
por: Muñiz-Sáenz-Diez, Javier, et al.
Publicado: (2023)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Safety and tolerability of intravenous regadenoson in healthy subjects: A randomized, repeat-dose, placebo-controlled study
por: Townsend, Robert, et al.
Publicado: (2015)

Regadenoson in the detection of coronary artery disease
por: Buhr, Christiane, et al.
Publicado: (2008)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Feasibility and results of acute cardiac stress MRI with regadenoson for risk stratification of COPD-patients with NSTEMI
por: Range, Felix T, et al.
Publicado: (2015)

Rare presentation of an atrial myxoma in an adolescent patient: a case report and literature review
por: Macias, Eduardo, et al.
Publicado: (2018)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

Determinants of myocardial perfusion reserve measured from coronary sinus phase-contrast imaging during regadenoson stress CMR
por: Bauml, Michael A, et al.
Publicado: (2014)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson
por: Bitar, Abbas, et al.
Publicado: (2015)

Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021)

Comparative Performances of Dipyridamole and Regadenoson to Detect Myocardial Ischemia using Cardiac Cadmium-Zinc-Telluride Single-Photon Emission Computerized Tomography
por: Ben Bouallègue, Fayçal, et al.
Publicado: (2018)

Time resolved measure of coronary sinus flow following regadenoson administration
por: Booker, O Julian, et al.
Publicado: (2011)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Diagnostic performance of regadenoson stress CMR for detection of coronary artery disease
por: Patel, Mita, et al.
Publicado: (2015)

Regadenoson stress induced wall motion abnormalities during cardiac MRI
por: Parikh, Kalindi, et al.
Publicado: (2015)

Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina
por: Beslic, Nermina, et al.
Publicado: (2016)

LV wall motion assessment during regadenoson vasodilator stress CMR
por: Jesinger, Michael, et al.
Publicado: (2016)

Regadenoson Stress Testing: A Comprehensive Review With a Focused Update
por: Elkholy, Karim O, et al.
Publicado: (2021)

Hemodynamic and Respiratory Effects of Regadenoson During Radiologic Imaging in Infants and Children
por: Schloss, Brian, et al.
Publicado: (2021)

Positive Regadenoson Stress Test in a Patient on Phentermine With Normal Coronaries
por: Sendil, Selin, et al.
Publicado: (2022)

Regadenoson blood flow in type 1 diabetes (RABIT(1)D Study)
por: Groves, Daniel W, et al.
Publicado: (2014)

Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge
por: Golzar, Yasmeen, et al.
Publicado: (2014)

Effects of adenosine and regadenoson on hemodynamics measured using cardiovascular magnetic resonance imaging
por: Thomas, Dustin M., et al.
Publicado: (2017)

Regadenoson Cardiac Stress Test-Induced Takotsubo Cardiomyopathy: A Case Report
por: Farid, Saira, et al.
Publicado: (2020)

Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023)

Passing the pmp exam: how to take it and pass it
por: McGary, Rudd
Publicado: (2005)

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012)

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
por: Bhave, Nicole M, et al.
Publicado: (2012)

Risk stratification by regadenoson stress MRI in patients with known or suspected coronary artery disease
por: Abbasi, Siddique A, et al.
Publicado: (2014)

Late Aminophylline Reversal of Regadenoson Stress Testing in Patients with End Stage Renal Disease
por: Abudiab, Muaz M., et al.
Publicado: (2014)

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing
por: Minor, Matthew, et al.
Publicado: (2015)

Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
por: Rafiq, Arsalan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kju411qia095tgf0uo3ivaj45h